{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1362825894257601792.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1056/nejmoa1509225"}},{"identifier":{"@type":"URI","@value":"http://www.nejm.org/doi/pdf/10.1056/NEJMoa1509225"}}],"dc:title":[{"@value":"Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome"}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1382825894257601795","@type":"Researcher","foaf:name":[{"@value":"Marc A. Pfeffer"}]},{"@id":"https://cir.nii.ac.jp/crid/1382825894257601926","@type":"Researcher","foaf:name":[{"@value":"Brian Claggett"}]},{"@id":"https://cir.nii.ac.jp/crid/1382825894257601922","@type":"Researcher","foaf:name":[{"@value":"Rafael Diaz"}]},{"@id":"https://cir.nii.ac.jp/crid/1382825894257601794","@type":"Researcher","foaf:name":[{"@value":"Kenneth Dickstein"}]},{"@id":"https://cir.nii.ac.jp/crid/1382825894257601925","@type":"Researcher","foaf:name":[{"@value":"Hertzel C. Gerstein"}]},{"@id":"https://cir.nii.ac.jp/crid/1382825894257601931","@type":"Researcher","foaf:name":[{"@value":"Lars V. Køber"}]},{"@id":"https://cir.nii.ac.jp/crid/1382825894257601928","@type":"Researcher","foaf:name":[{"@value":"Francesca C. Lawson"}]},{"@id":"https://cir.nii.ac.jp/crid/1382825894257601927","@type":"Researcher","foaf:name":[{"@value":"Lin Ping"}]},{"@id":"https://cir.nii.ac.jp/crid/1382825894257601923","@type":"Researcher","foaf:name":[{"@value":"Xiaodan Wei"}]},{"@id":"https://cir.nii.ac.jp/crid/1382825894257601792","@type":"Researcher","foaf:name":[{"@value":"Eldrin F. Lewis"}]},{"@id":"https://cir.nii.ac.jp/crid/1382825894257601920","@type":"Researcher","foaf:name":[{"@value":"Aldo P. Maggioni"}]},{"@id":"https://cir.nii.ac.jp/crid/1382825894257601793","@type":"Researcher","foaf:name":[{"@value":"John J.V. McMurray"}]},{"@id":"https://cir.nii.ac.jp/crid/1382825894257601930","@type":"Researcher","foaf:name":[{"@value":"Jeffrey L. Probstfield"}]},{"@id":"https://cir.nii.ac.jp/crid/1382825894257601924","@type":"Researcher","foaf:name":[{"@value":"Matthew C. Riddle"}]},{"@id":"https://cir.nii.ac.jp/crid/1382825894257601921","@type":"Researcher","foaf:name":[{"@value":"Scott D. Solomon"}]},{"@id":"https://cir.nii.ac.jp/crid/1382825894257601929","@type":"Researcher","foaf:name":[{"@value":"Jean-Claude Tardif"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"00284793"},{"@type":"EISSN","@value":"15334406"}],"prism:publicationName":[{"@value":"New England Journal of Medicine"}],"dc:publisher":[{"@value":"Massachusetts Medical Society"}],"prism:publicationDate":"2015-12-03","prism:volume":"373","prism:number":"23","prism:startingPage":"2247","prism:endingPage":"2257"},"reviewed":"false","url":[{"@id":"http://www.nejm.org/doi/pdf/10.1056/NEJMoa1509225"}],"createdAt":"2015-12-02","modifiedAt":"2017-05-08","relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1050282810834269440","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Japanese Clinical Practice Guideline for Diabetes 2016"},{"@value":"The Japan Diabetes Society. Japanese Clinical Practice Guideline for Diabetes 2016"}]},{"@id":"https://cir.nii.ac.jp/crid/1050579753469995648","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Efficacy of antihyperglycemic therapies on cardiovascular and heart failure outcomes: an updated meta-analysis and meta-regression analysis of 35 randomized cardiovascular outcome trials"}]},{"@id":"https://cir.nii.ac.jp/crid/1360009142463909888","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"GLP-1 Receptor Agonists in Diabetic Kidney Disease: From Clinical Outcomes to Mechanisms"}]},{"@id":"https://cir.nii.ac.jp/crid/1360009142798414592","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"An emerging new concept for the management of type 2 diabetes with a paradigm shift from the glucose-centric to beta cell-centric concept of diabetes - an Asian perspective"}]},{"@id":"https://cir.nii.ac.jp/crid/1360019687863404288","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Common Drug Pipelines for the Treatment of Diabetic Nephropathy and Hepatopathy: Can We Kill Two Birds with One Stone?"}]},{"@id":"https://cir.nii.ac.jp/crid/1360021390764333696","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Effects of incretin-based therapeutic agents including tirzepatide on renal outcomes in patients with type 2 diabetes: A systemic review and meta-analysis"}]},{"@id":"https://cir.nii.ac.jp/crid/1360022305565316864","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Cardiovascular and Renal Outcomes with SGLT-2 Inhibitors Versus GLP-1 Receptor Agonists in Patients with Type 2 Diabetes Mellitus and Chronic Kidney Disease: A Systematic Review and Network Meta-Analysis"}]},{"@id":"https://cir.nii.ac.jp/crid/1360285705151293312","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Challenges to hemoglobin A1c as a therapeutic target for type 2 diabetes mellitus"}]},{"@id":"https://cir.nii.ac.jp/crid/1360294643729005696","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Comparison of effects of SGLT-2 inhibitors and GLP-1 receptor agonists on cardiovascular and renal outcomes in type 2 diabetes mellitus patients with/without albuminuria: A systematic review and network meta-analysis"}]},{"@id":"https://cir.nii.ac.jp/crid/1360294643858809856","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Effects of glucagon‐like peptide‐1 receptor agonists on cardiovascular and renal outcomes: A\n                    <scp>meta‐analysis</scp>\n                    and\n                    <scp>meta‐regression</scp>\n                    analysis"}]},{"@id":"https://cir.nii.ac.jp/crid/1360298338456493440","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Exenatide Once Weekly for Management of Type 2 Diabetes: A Review"}]},{"@id":"https://cir.nii.ac.jp/crid/1360305195944360320","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"JCS/JHFS 2025 Guideline on Diagnosis and Treatment of Heart Failure"}]},{"@id":"https://cir.nii.ac.jp/crid/1360576118762245376","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Systematic review and meta-analysis for prevention of cardiovascular complications using GLP-1 receptor agonists and SGLT-2 inhibitors in obese diabetic patients"}]},{"@id":"https://cir.nii.ac.jp/crid/1360584340527259008","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Current findings on the efficacy of incretin-based drugs for diabetic kidney disease: A narrative review"}]},{"@id":"https://cir.nii.ac.jp/crid/1360584340531809152","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Cancer biology in diabetes update: Focusing on antidiabetic drugs"}]},{"@id":"https://cir.nii.ac.jp/crid/1360848659831381760","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Dipeptidyl peptidase-4 inhibition and renoprotection"}]},{"@id":"https://cir.nii.ac.jp/crid/1360848664423295616","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Incretin-Based Therapies for Diabetic Complications: Basic Mechanisms and Clinical Evidence"}]},{"@id":"https://cir.nii.ac.jp/crid/1360849946837865216","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Imbalance in glycemic control between the treatment and placebo groups in cardiovascular outcome trials in type 2 diabetes"}]},{"@id":"https://cir.nii.ac.jp/crid/1360853567539616768","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Approvals of type 2 diabetes drugs tested in cardiovascular outcome trials: A tripartite comparison"}]},{"@id":"https://cir.nii.ac.jp/crid/1360853567674531840","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Treatment of Diabetic Kidney Disease: Current and Future"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001205274859136","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Cardiovascular Disease in Japanese Patients with Type 2 Diabetes Mellitus"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001206449367424","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"ja","@value":"糖尿病治療薬による心血管疾患予防効果"},{"@language":"en","@value":"Protective Effect of Anti-diabetic Drugs on Cardiovascular Diseases"}]},{"@id":"https://cir.nii.ac.jp/crid/1390013939079869824","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Paradigm sift of the medical care in diabetes"},{"@language":"ja","@value":"糖尿病薬物治療の新展開"}]},{"@id":"https://cir.nii.ac.jp/crid/1390290172818748160","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"JCS/JHFS 2021 Guideline Focused Update on Diagnosis and Treatment of Acute and Chronic Heart Failure"},{"@value":"Guideline focused update on diagnosis and treatment of acute and chronic heart failure"}]},{"@id":"https://cir.nii.ac.jp/crid/1390564237989450368","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Effects of a Dipeptidyl Peptidase 4 Inhibitor Sitagliptin on Glycemic Control and Lipoprotein Metabolism in Patients with Type 2 Diabetes Mellitus (GLORIA Trial)"}]},{"@id":"https://cir.nii.ac.jp/crid/1390575520370017792","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Effects of GLP-1 Receptor Agonists on Cardiovascular Events and Their Clinical Positioning"},{"@language":"ja","@value":"GLP-1受容体作動薬の心血管イベントに対する効果と臨床上のポジショニング"}]},{"@id":"https://cir.nii.ac.jp/crid/1390586444064892800","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"JCS/JHFS 2025 Guideline on Diagnosis and Treatment of Heart Failure"}]},{"@id":"https://cir.nii.ac.jp/crid/1390846609810687360","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"3. Recent Progress in the Treatment of Type 2 Diabetes"},{"@language":"ja","@value":"3．2型糖尿病治療：最新の動向"},{"@value":"2型糖尿病治療 : 最新の動向"},{"@language":"ja-Kana","@value":"2ガタ トウニョウビョウ チリョウ : サイシン ノ ドウコウ"}]},{"@id":"https://cir.nii.ac.jp/crid/1391131406293094272","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Diagnosis, Prevention, and Treatment of Cardiovascular Diseases in People With Type 2 Diabetes and Prediabetes　― A Consensus Statement Jointly From the Japanese Circulation Society and the Japan Diabetes Society ―"}]},{"@id":"https://cir.nii.ac.jp/crid/1523951030061134848","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"GUIDELINE : Japanese Clinical Practice Guideline for Diabetes 2019"}]},{"@id":"https://cir.nii.ac.jp/crid/2050588892104608640","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Renoprotective effect of GLP-1 receptor agonist, liraglutide, in early-phase diabetic kidney disease in spontaneously diabetic Torii fatty rats"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1056/nejmoa1509225"},{"@type":"CROSSREF","@value":"10.1007/s13340-020-00471-5_references_DOI_Wqmly5ObIJLISKC6xNliiFrDOiE"},{"@type":"CROSSREF","@value":"10.3389/fphar.2020.00967_references_DOI_Wqmly5ObIJLISKC6xNliiFrDOiE"},{"@type":"CROSSREF","@value":"10.1080/14656566.2020.1776262_references_DOI_Wqmly5ObIJLISKC6xNliiFrDOiE"},{"@type":"CROSSREF","@value":"10.1007/s10157-020-02007-2_references_DOI_Wqmly5ObIJLISKC6xNliiFrDOiE"},{"@type":"CROSSREF","@value":"10.3390/ijms21144939_references_DOI_Wqmly5ObIJLISKC6xNliiFrDOiE"},{"@type":"CROSSREF","@value":"10.1016/j.metop.2023.100236_references_DOI_Wqmly5ObIJLISKC6xNliiFrDOiE"},{"@type":"CROSSREF","@value":"10.1002/jgf2.244_references_DOI_Wqmly5ObIJLISKC6xNliiFrDOiE"},{"@type":"CROSSREF","@value":"10.1111/jdi.12810_references_DOI_Wqmly5ObIJLISKC6xNliiFrDOiE"},{"@type":"CROSSREF","@value":"10.1016/j.diabres.2021.109146_references_DOI_Wqmly5ObIJLISKC6xNliiFrDOiE"},{"@type":"CROSSREF","@value":"10.1111/dom.14666_references_DOI_Wqmly5ObIJLISKC6xNliiFrDOiE"},{"@type":"CROSSREF","@value":"10.2147/cpaa.s288846_references_DOI_Wqmly5ObIJLISKC6xNliiFrDOiE"},{"@type":"CROSSREF","@value":"10.1253/circj.cj-20-0865_references_DOI_Wqmly5ObIJLISKC6xNliiFrDOiE"},{"@type":"CROSSREF","@value":"10.1007/s13340-020-00439-5_references_DOI_Wqmly5ObIJLISKC6xNliiFrDOiE"},{"@type":"CROSSREF","@value":"10.1016/j.cardfail.2021.04.023_references_DOI_Wqmly5ObIJLISKC6xNliiFrDOiE"},{"@type":"CROSSREF","@value":"10.1038/s41598-021-89620-7_references_DOI_Wqmly5ObIJLISKC6xNliiFrDOiE"},{"@type":"CROSSREF","@value":"10.1186/s12933-023-01773-z_references_DOI_Wqmly5ObIJLISKC6xNliiFrDOiE"},{"@type":"CROSSREF","@value":"10.1016/j.biopha.2023.115032_references_DOI_Wqmly5ObIJLISKC6xNliiFrDOiE"},{"@type":"CROSSREF","@value":"10.1111/jdi.14152_references_DOI_Wqmly5ObIJLISKC6xNliiFrDOiE"},{"@type":"CROSSREF","@value":"10.1253/circj.cj-25-0002_references_DOI_Wqmly5ObIJLISKC6xNliiFrDOiE"},{"@type":"CROSSREF","@value":"10.1007/s13340-018-0345-3_references_DOI_Wqmly5ObIJLISKC6xNliiFrDOiE"},{"@type":"CROSSREF","@value":"10.3390/ijms17081223_references_DOI_Wqmly5ObIJLISKC6xNliiFrDOiE"},{"@type":"CROSSREF","@value":"10.5551/jat.41343_references_DOI_Wqmly5ObIJLISKC6xNliiFrDOiE"},{"@type":"CROSSREF","@value":"10.1186/s40545-019-0193-y_references_DOI_Wqmly5ObIJLISKC6xNliiFrDOiE"},{"@type":"CROSSREF","@value":"10.2169/naika.106.1029_references_DOI_Wqmly5ObIJLISKC6xNliiFrDOiE"},{"@type":"CROSSREF","@value":"10.1253/circj.cj-21-0431_references_DOI_Wqmly5ObIJLISKC6xNliiFrDOiE"},{"@type":"CROSSREF","@value":"10.1111/jdi.13306_references_DOI_Wqmly5ObIJLISKC6xNliiFrDOiE"},{"@type":"CROSSREF","@value":"10.1111/bcp.14814_references_DOI_Wqmly5ObIJLISKC6xNliiFrDOiE"},{"@type":"CROSSREF","@value":"10.4093/dmj.2020.0217_references_DOI_HCcDgAPEFQwhwO8lahEM2qGv74t"},{"@type":"CROSSREF","@value":"10.1186/s12933-020-01197-z_references_DOI_Wqmly5ObIJLISKC6xNliiFrDOiE"},{"@type":"CROSSREF","@value":"10.1272/manms.19.32_references_DOI_Wqmly5ObIJLISKC6xNliiFrDOiE"},{"@type":"CROSSREF","@value":"10.2169/naika.110.2458_references_DOI_Wqmly5ObIJLISKC6xNliiFrDOiE"},{"@type":"CROSSREF","@value":"10.1101/2021.10.14.21264803_references_DOI_Wqmly5ObIJLISKC6xNliiFrDOiE"},{"@type":"CROSSREF","@value":"10.1016/j.cardfail.2025.02.014_references_DOI_Wqmly5ObIJLISKC6xNliiFrDOiE"},{"@type":"CROSSREF","@value":"10.3400/avd.ra.17-00109_references_DOI_Wqmly5ObIJLISKC6xNliiFrDOiE"},{"@type":"CROSSREF","@value":"10.1097/mnh.0000000000000291_references_DOI_Wqmly5ObIJLISKC6xNliiFrDOiE"},{"@type":"CROSSREF","@value":"10.2169/naika.108.460_references_DOI_Wqmly5ObIJLISKC6xNliiFrDOiE"}]}